跳至主要内容
临床试验/NCT01558856
NCT01558856已完成不适用

Prospective Randomized Trial Comparing Unilateral and Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

Centre Hospitalier Universitaire de Nīmes12 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2012年10月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
试验地点
12
主要终点
Success rate

研究概览

简要总结

The primary objective of this study is to compare the efficacy of unilateral and bilateral neuromodulation tests at 1 month.

详细描述

The secondary objectives of this study are to compare the following elements between a group of patients undergoing unilater modulation tests (standard procedure) and a group of patients undergoing bilateral neuromodulation tests (experimental procedure) (at 1 month): Pollakiuria, pad use, urge incontinence, symptom severity, % of patients not eligible for an implant, debimetry, tolerance, complications, quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 1 month of follow-up
  • The patient understands and reads French
  • The patient has symptoms of overactive bladder resistant to first-line treatments (physiotherapy, anticholinergics)
  • The patient suffers from an overactive bladder confirmed by a urodynamic panel
  • The patient suffers from an overactive bladder unassociated with bladder obstruction as confirmed by flowmetry
  • The patient has primary (idiopathic) overactive bladder primary with normal urinalysis, abdominal and pelvic ultrasound, urine cytology + / - cystoscopy
  • The patient has no bleeding disorders, or the disorder is properly controlled after treatment

排除标准

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • Overactive bladder associated with bladder obstruction as determined by flowmetry
  • Overactive bladder unconfirmed by urodynamic panel
  • Overactive bladder secondary to another condition:
  • vesical: urolithiasis, bladder polyp, interstitial cystitis
  • pelivienne: tumor or inflammatory
  • neurological: multiple sclerosis, brain tumor, epilepsy
  • the patient has an uncorrectable bleeding disorder

结局指标

主要结局

Success rate

时间窗: 1 month

"Success" is defined as a \>= 50% improvement in at least one of the following symtoms: pollakiuria, number of urge incontinence episodes with incontinence, number of urge incontinence episodes.

次要结局

  • Presence/absence of infection of the implant or electrode(1 month)
  • presence/absence: 50% reduction in the number of urge incontinence episodes per day(1 month)
  • debimetry: urinary volume per voiding(1 month)
  • presence/absence: 50% reduction in the number of daily mictions(1 month)
  • Symptom severity as measured by the MHU score(1 month)
  • Visual analog scale for pain due to neuro stimulation (pain in legs or buttocks)(1 month)
  • Change in quality of life: IQoL score(baseline to 1 month)
  • presence/absence: 50% reduction in the number of urge incontinence episodes with incontinence per day(1 month)
  • debimetry: flow rate per voiding(1 month)
  • Change in quality of life: SF 36 score(baseline to 1 month)
  • presence/absence: 50% reduction in the number of pads/protections used per day(1 month)
  • Yes/no: the patient was eligible for an implant(1 month)
  • Visual analog scale for pain at the implantation site(1 month)
  • Change in quality of life: KHQ score(baseline to 1 month)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验